Literature DB >> 12376521

Sensitivity of electrospray ionization mass spectrometry detection of codon 249 mutations in the p53 gene compared with RFLP.

Geng-Sun Qian1, Shuang-Yuan Kuang, Xia He, John D Groopman, Peta E Jackson.   

Abstract

Hepatocellular carcinoma (HCC) has several major etiological risk factors, including infection with hepatitis viruses and exposure to aflatoxin B(1). A specific missense mutation resulting from a guanine to thymine transversion at the third position of codon 249 in the p53 tumor suppressor gene has been reported in 10-70% of HCCs from areas of high dietary exposure to aflatoxin B(1.) This mutation has not only been detected in tumor samples but has also been measured in DNA isolated from the blood of patients with HCC in two separate studies by two independent methods: RFLP and short oligonucleotide mass analysis (SOMA), an electrospray ionization mass spectrometry technique. To compare the relative sensitivities of these methodologies, a set of serially diluted samples was analyzed by both techniques. The detection limits of RFLP and SOMA were 6% and 2.4% mutant alleles in the presence of wild-type alleles, respectively. When the DNA samples were predigested with HaeIII before SOMA, the detection limit was improved to 0.4% mutant allele in the presence of wild-type alleles. We have therefore found that SOMA is about 2.5-15-fold more sensitive than RFLP for detection of specific p53 mutations. A set of 26 DNA samples from HCC and normal liver was analyzed by RFLP and SOMA, and 5 samples were positive for the p53 mutation. An additional 4 samples were found to be positive for the mutation when SOMA was repeated after HaeIII predigestion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376521

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  7 in total

1.  Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.

Authors:  Xing-Hua Huang; Lu-Hong Sun; Dong-Dong Lu; Yan Sun; Li-Jie Ma; Xi-Ran Zhang; Jian Huang; Long Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids.

Authors:  Vaneet K Sharma; Paul Vouros; James Glick
Journal:  Int J Mass Spectrom       Date:  2011-07       Impact factor: 1.986

3.  GenoMass software: a tool based on electrospray ionization tandem mass spectrometry for characterization and sequencing of oligonucleotide adducts.

Authors:  Vaneet K Sharma; James Glick; Qing Liao; Chang Shen; Paul Vouros
Journal:  J Mass Spectrom       Date:  2012-04       Impact factor: 1.982

Review 4.  Clinical outcomes and correlates of TP53 mutations and cancer.

Authors:  Ana I Robles; Curtis C Harris
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-03       Impact factor: 10.005

5.  Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis.

Authors:  Matilde E Lleonart; Santiago Ramón y Cajal; John D Groopman; Marlin D Friesen
Journal:  Nucleic Acids Res       Date:  2004-03-22       Impact factor: 16.971

6.  Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma.

Authors:  Markus W Löffler; Christopher Mohr; Leon Bichmann; Lena Katharina Freudenmann; Mathias Walzer; Christopher M Schroeder; Nico Trautwein; Franz J Hilke; Raphael S Zinser; Lena Mühlenbruch; Daniel J Kowalewski; Heiko Schuster; Marc Sturm; Jakob Matthes; Olaf Riess; Stefan Czemmel; Sven Nahnsen; Ingmar Königsrainer; Karolin Thiel; Silvio Nadalin; Stefan Beckert; Hans Bösmüller; Falko Fend; Ana Velic; Boris Maček; Sebastian P Haen; Luigi Buonaguro; Oliver Kohlbacher; Stefan Stevanović; Alfred Königsrainer; Hans-Georg Rammensee
Journal:  Genome Med       Date:  2019-04-30       Impact factor: 11.117

7.  Qidong hepatitis B virus infection cohort: a 25-year prospective study in high risk area of primary liver cancer.

Authors:  Taoyang Chen; Gengsun Qian; Chunsun Fan; Yan Sun; Jinbing Wang; Peixin Lu; Xuefeng Xue; Yan Wu; Qinan Zhang; Yan Jin; Yiqian Wu; Yu Gan; Jianquan Lu; Thomas W Kensler; John D Groopman; Hong Tu
Journal:  Hepatoma Res       Date:  2018-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.